MG
Mary E. Godwin
Senior VP, Operations

Mary E. Godwin insider trades: Nautilus Biotechnology (NAUT) stock sales

Senior VP, Operations, Nautilus Biotechnology Last trade Sep 23, 2024 19 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2010
2
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Mary reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Sep 23, 2024NAUT↓ Sell$135K
Sep 17, 2024NAUT↓ Sell$100K
Nov 24, 2010ISLN↓ Sell$158K
Nov 12, 2010ISLN↓ Sell$120K
Oct 25, 2010ISLN↓ Sell$138K
Oct 12, 2010ISLN↓ Sell$118K
Sep 24, 2010ISLN↓ Sell$111K
Sep 13, 2010ISLN↓ Sell$108K
Aug 24, 2010ISLN↓ Sell$92K
Aug 18, 2010ISLN↓ Sell$14K
May 18, 2010ISLN↓ Sell$71K
Apr 26, 2010ISLN↓ Sell$552K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other NAUT insiders

Open-market trades in the last 12 months

About Mary E. Godwin's insider trades

Mary E. Godwin is Senior VP, Operations at Nautilus Biotechnology (NAUT). Since Apr 26, 2010, Mary has reported no open-market purchases and 12 sales worth $1.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (11 filings), grants and awards (6 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAUT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.